The discovery of rearrangements inducing the overexpression of TERT in the absence of MYCN-amplification [11,17] or the mechanisms of the alternative lengthening of telomeres (ALT), often due to mutation or deletion of ATRX [18], identified telomere maintenance as a feature defining high-risk neuroblastomas [11,13]. This evidence concerns the gene TERT and neuroblastoma.